Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the use and efficacy of the Reverse® Shoulder Prosthesis for treatment of rotator cuff deficiency in subjects who are candidates for a total shoulder replacement (primary and revision subjects).


Clinical Trial Description

Reverse shoulder arthroplasty for the treatment of rotator cuff deficiency and glenohumeral arthritis have shown favorable outcomes in pain and function over the short and medium term. A prospective, multi-center study on the outcomes of subjects treated with the RSP would be a valuable addition to the literature and give important information regarding an ever-increasing treatment option for subjects with rotator cuff deficiency. The study will take place at multiple sites across the United States and will be managed by the DJO Surgical Clinical Affairs Department. The study will include only subjects who meet the indications for use criteria for the Reverse® Shoulder Prosthesis and who are candidates for total shoulder replacement surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01005446
Study type Observational
Source Encore Medical, L.P.
Contact
Status Completed
Phase
Start date December 2009
Completion date June 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05488847 - Opioid-Free Pain Protocol After Shoulder Arthroplasty Phase 4
Active, not recruiting NCT05940974 - Quality of Life, Functional Outcomes and Costs in Shoulder Arthroplasty
Active, not recruiting NCT05170321 - Analysis of Influencing Factors and Construction of Prediction Models of Artificial Joint Replacement in China
Completed NCT03573765 - Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data
Completed NCT01937559 - Topical Tranexamic Acid (TXA) in Joint Arthroplasty Phase 4